Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview


See Plans and Pricing

« Back to Dashboard

When do Blephamide S.o.p patents expire, and what generic alternatives are available?

Blephamide S.o.p is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in BLEPHAMIDE S.O.P is prednisolone acetate; sulfacetamide sodium. There are eighty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the prednisolone acetate; sulfacetamide sodium profile page.

Summary for BLEPHAMIDE S.O.P
US Patents:0
Formulation / Manufacturing:see details
DailyMed Link:BLEPHAMIDE S.O.P at DailyMed
Drug patent expirations by year for BLEPHAMIDE S.O.P

US Patents and Regulatory Information for BLEPHAMIDE S.O.P

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan BLEPHAMIDE S.O.P. prednisolone acetate; sulfacetamide sodium OINTMENT;OPHTHALMIC 087748-001 Dec 3, 1986 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.